09:45 EDT Avalo Therapeutics trading halted, volatility trading pause
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AVTX:
- Avalo Therapeutics Shareholders Back Board and Strategies
- Avalo Reports Second Quarter 2024 Financial Results and Provides Business Updates
- Avalo Therapeutics sees cash runway into 2027
- Avalo Therapeutics reports Q2 EPS ($14.07) vs. ($140.73) last year
- Avalo Therapeutics Welcomes New CMO with Competitive Package